IRIS
SAVARINO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 51.217
AS - Asia 108
SA - Sud America 41
AF - Africa 1
NA - Nord America 1
Totale 51.368
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 51.217
CN - Cina 89
BR - Brasile 34
VN - Vietnam 9
SG - Singapore 4
AR - Argentina 3
CL - Cile 2
ID - Indonesia 2
IQ - Iraq 2
BD - Bangladesh 1
IN - India 1
PY - Paraguay 1
US - Stati Uniti d'America 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 51.368
Salva come PNG Salva come JPEG
Città #
Genova 33.728
Genoa 10.445
Rapallo 4.096
Vado Ligure 2.886
Bordighera 62
Beijing 36
Hanoi 4
Singapore 3
São Paulo 3
Fortaleza 2
Ho Chi Minh City 2
Rio de Janeiro 2
Ashburn 1
Bandung 1
Basra 1
Biên Hòa 1
Brumado 1
Buenos Aires 1
Cachoeira do Sul 1
Camaquã 1
Cambé 1
Campo Largo 1
Campos Gerais 1
Campos dos Goytacazes 1
Canoas 1
Carlópolis 1
Catanduva 1
Charallave 1
Concepción 1
Congonhas 1
Cruzeiro 1
Curitiba 1
Córdoba 1
Estación Colina 1
Feira de Santana 1
Florianópolis 1
Groblersdal 1
Haiphong 1
Ituzaingó 1
João Monlevade 1
Juiz de Fora 1
Limeira 1
Mairi 1
Manaus 1
Nantong 1
Nasiriyah 1
Parnaíba 1
Paty do Alferes 1
Ribeirão das Neves 1
Satna 1
Sorocaba 1
Suzano 1
São Gonçalo 1
Valparaíso de Goiás 1
Totale 51.311
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 221
5-ASA and colorectal cancer chemoprevention in inflammatory bowel disease: can we afford to wait for “best evidence”? 190
Proton pump inhibitors: use and misuse in the clinical setting 185
Time pattern of gastric acidity in Barrett's esophagus 183
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 180
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 179
13C-mixed triglyceride (13C-MTG) breath-test (BT) in Cystic Fibrosis (CF). 178
Positive PET in a patient with esophageal leiomyoma. 178
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 177
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 177
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 176
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 175
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 173
Circadian monitoring of gastric juice mutagenicity. 172
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 172
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 170
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 169
A safety review of proton pump inhibitors to treat acid-related digestive diseases 169
Barrett's esophagus in 2016: From pathophysiology to treatment 168
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 168
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 167
Are proton pump inhibitors really so dangerous? 166
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 165
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 164
Measurement of sorafenib plasma concentration by high-performance liquid chromatography in patients with advanced hepatocellular carcinoma: is it useful the application in clinical practice? A pilot study 164
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication 164
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. 163
Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis 162
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 162
Breath tests to assess alcoholic liver disease. 162
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 161
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 161
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up 160
Measurement of oro-caecal transit time by magnetic resonance imaging. 160
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 160
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. 159
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 158
Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial. 158
Ilaprazole for the treatment of gastro-esophageal reflux 158
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 157
High anti-TNF alfa drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel disease 157
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 156
24-hour study of intragastric acidity in duodenal ulcer patients and normal subjects using continuous intraluminal pH-metry. 156
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 156
Burden of illness in Italian patients with gastro-oesophageal reflux disease. 155
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 155
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 155
Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. 155
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 155
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 154
Circadian reduction of chromium in the gastric environment. 154
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy 154
Can artificial neural networks be beneficial in diagnosing gastro-oesophageal reflux disease? 154
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 154
A comparison of five maintenance therapies for reflux esophagitis 153
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 152
24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration. 151
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 150
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 150
Acid and gastric metaplasia in the duodenum 149
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 149
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 149
A Nodule, is a Nodule, is a Nodule: May Alpha-fetoprotein Make the Difference? 149
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 149
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 147
Adalimumab trough levels and response to biological treatment in patients with Inflammatory Bowel Disease: a useful cut-off In clinical practice. 147
An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic hepatitis C virus infection and advanced liver disease 146
Impact of evidence-based medicine on treatment of patients with unresectable hepatocellular carcinoma 146
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease. 146
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 146
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. 145
External Validation of the Platelet Count/Spleen Diameter Ratio for the Diagnosis of Esophageal Varices in Hepatitis C Virus-Related Cirrhosis 145
Letter: Biologics are effective in neutralising the detrimental effect of smoking on the natural course of Crohn's disease 145
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 145
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 144
Blessed are those who have not seen and yet have believed 144
Starry Liver: An Unexpected Diagnosis 144
Anti-TNF Antibodies For Prevention of Crohn's Disease Recurrence After Surgery: More Than An Hope. 144
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 143
OAM for cure of Helicobacter pylori infection. 143
NERD: an umbrella term including heterogeneous subpopulations. 143
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 142
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 142
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab. 142
The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up 142
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 141
Infliximab trough levels and persistent vs transient antibodies measured early after induction predict long-term clinical remission in patients with inflammatory bowel disease 141
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 140
Comparison between laparoscopy, ultrasonography, and computed tomography in widespread and localized liver diseases. 140
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. 138
Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs pantoprazole. 137
Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. 137
Discriminant value of dyspepsia subgroups. 137
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 137
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. 136
Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques. 136
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 136
Optimal management of constipation associated with irritable bowel syndrome. 136
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases 136
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 136
Totale 15.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.052
article - articoli 150.053
book - libri 447
conference - conferenze 2.325
curatela - curatele 0
other - altro 7.971
patent - brevetti 0
selected - selezionate 0
volume - volumi 256
Totale 322.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.408 0 0 0 333 174 294 123 332 317 354 224 257
2021/20225.241 161 297 378 744 235 408 388 1.125 212 497 177 619
2022/20234.913 530 265 60 424 947 890 6 379 886 32 437 57
2023/20242.217 117 319 50 224 185 396 129 100 138 39 142 378
2024/20257.016 275 599 263 452 959 718 570 1.066 279 293 695 847
2025/20263.580 1.420 298 927 935 0 0 0 0 0 0 0 0
Totale 51.981